SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

Share Price is delayed by 15 minutes
Get Live Data
3.75    0.00 (0.00%)
Bid:
3.50
Ask:
4.00
Spread: 0.50 (14.286%)
Market Cap: £1.04m
SNT Live PriceLast checked at - London Stock Exchange

Intraday Sabien Tech. Share Chart

Trading Statement

1 Jun 2007 11:31

Sabien Technology Group PLC01 June 2007 SABIEN TECHNOLOGY GROUP PLC ("SABIEN") TRADING UPDATE Sabien Technology Group Plc is updating the market ahead of the financial yearending 30 June 2007. On announcing its unaudited interim results for the six month period to 31December 2006 on 31 March 2007, the Board made reference to the fact that thethree month delay in admission of its shares to trading on AIM led to thedeferment of the recruitment of sales staff and the implementation of othercorporate initiatives which, in turn, meant that certain predicted revenueswould be deferred into the financial year ending 30 June 2008. In addition, the Company is also finding that whilst it is in negotiation with asignificant number of potential users of the M2G product, the time taken inconverting leads into purchase orders is proving to take significantly longerthan anticipated at the time of flotation due to these users often being unableto measure energy consumption accurately and thus quantify savings derived fromusing M2G. Following a detailed review of the current order book and sales pipeline, theBoard now confirms that the results for the financial year ending 30 June 2007are likely to be considerably below market expectations and the Company islikely to report a loss before tax for the full year of around £0.75 million. The Board is pleased to report however that, during the company's second halfyear, a number of major organisations have committed to the use of Sabien's M2Gtechnology and the company will continue to implement its strategy to achievesubstantial market penetration. Future Developments As announced on 24 May 2007, the company's main client, RBS, continues to enjoysubstantial environmental and financial benefits as a result of the adoption ofSabien's M2G technology across 200 of their commercial sites and a furtherroll-out of units is scheduled to continue throughout the next 12 months. In addition, Sabien is currently in advanced negotiations with a prospectiveItalian licensee. Whilst there can be no guarantee of positive outcomes, thesenegotiations may result in unbudgeted licence and other revenue streams and theBoard will update the market accordingly. Further, the Board confirms that the company is launching a strategic initiativetargeting a number of large multi-site commercial organisations. Theseorganisations are being approached to participate in a three month contractedpilot scheme under which the proven energy and emission reduction advantages ofSabien M2G technology will be made available to them. The company is also looking at ways of incorporating meter and monitoring intoits product offering in order to counter the long sales lead times due tocustomers' inability to measure their energy consumption. Following the results of these initiatives, the Board will have a clearer viewof the likely target for the year ending 30 June 2008 and will update the marketaccordingly. Contact: Sabien Technology Group Plc Alan O'Brien CEO 020 7993 3700 Gus Orchard Finance Director Gavin Anderson Ken Cronin 020 7554 1400 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
16th Dec 201912:30 pmRNSIssue of Equity
5th Dec 20194:30 pmRNSResult of AGM
13th Nov 20195:15 pmRNSNotice of AGM
6th Nov 20197:00 amRNSHolding(s) in Company
5th Nov 20197:00 amRNSDirectorate Change
4th Nov 201911:30 amRNSHolding(s) in Company
1st Nov 20191:00 pmRNSHolding(s) in Company
31st Oct 20195:00 pmRNSHolding(s) in Company
29th Oct 201911:05 amRNSSecond Price Monitoring Extn
29th Oct 201911:00 amRNSPrice Monitoring Extension
29th Oct 20199:05 amRNSSecond Price Monitoring Extn
29th Oct 20199:00 amRNSPrice Monitoring Extension
18th Oct 20192:47 pmRNSCorporate Update
30th Sep 20192:37 pmRNSTotal Voting Rights
27th Sep 20197:00 amRNSFinal Results
24th Sep 20197:00 amRNSBoard Changes
20th Sep 201910:51 amRNSHolding(s) in Company
10th Sep 201910:59 amRNSHolding(s) in Company
10th Sep 201910:56 amRNSHolding(s) in Company
3rd Sep 20197:00 amRNSBoard changes, subscription and trading update
28th Jun 20193:38 pmRNSHolding(s) in Company
11th Jun 20191:46 pmRNSNew contract award and trading update
30th May 20197:00 amRNSHolding(s) in Company
13th May 20197:00 amRNSPlacing
2nd Apr 20197:00 amRNSCorporate Update - Contract Win
14th Feb 20197:00 amRNSHalf-year Report
12th Feb 201910:29 amRNSHolding(s) in Company
12th Feb 201910:24 amRNSHolding(s) in Company
12th Feb 201910:24 amRNSHolding(s) in Company
4th Feb 20193:20 pmRNSCorporate Update - Orders Received
17th Jan 20197:00 amRNSDirectorate Change
21st Dec 20182:54 pmRNSResult of AGM and Board change
20th Dec 201810:29 amRNSDirector/PDMR Shareholding
20th Dec 201810:27 amRNSHolding(s) in Company
17th Dec 20183:47 pmRNSHolding(s) in Company
17th Dec 20182:54 pmRNSHolding(s) in Company
17th Dec 20182:50 pmRNSHolding(s) in Company
17th Dec 20182:49 pmRNSHolding(s) in Company
17th Dec 20187:00 amRNSHolding(s) in Company
13th Dec 20182:09 pmRNSResult of General Meeting and Board changes
28th Nov 20185:49 pmRNSNotice of AGM
28th Nov 20185:29 pmRNSAnnual Financial Report
27th Nov 20183:21 pmRNSNotice of GM
23rd Nov 201812:07 pmRNSConditional placing and proposed board changes
19th Nov 20185:47 pmRNSHolding(s) in Company
30th Aug 20184:36 pmRNSResult of Meeting, Change of Registered Office
7th Jun 20187:00 amRNSCorporate Update New Order Received
2nd May 201810:51 amRNSTotal Voting Rights
27th Mar 20184:33 pmRNSPDMR Shareholding
26th Mar 20187:00 amRNSFundraise and appointment of sole broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.